CMRE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
CMRE is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has some constructive long-term positives, especially the recent analyst upgrades and higher dividend, but the current technical trend is still bearish and the proprietary trading signals show no strong entry trigger today. Given the mixed setup, the better call is to hold and wait for clearer price strength before buying.
The technical picture is weak. MACD histogram is negative at -0.117, though it is contracting, which suggests downside momentum is easing. RSI_6 at 32.233 is near oversold but still not a clean bullish reversal signal. Moving averages remain bearish with SMA_200 > SMA_20 > SMA_5, showing the broader trend is still down. Price closed at 14.26, below the pivot resistance area of 14.722, with immediate support at 14.044 and deeper support at 13.625. Short-term pattern analysis also points to softness over the next week and month.
["Freedom Broker upgraded CMRE to Buy and raised the price target to $21 from $19 after Q1 results.", "Fearnley also upgraded the stock to Buy with a $21 price target.", "Costamare increased its quarterly dividend by 8.7% to $0.125 per share, which supports shareholder returns.", "The company added 16 new containerships, improving long-term cash flow visibility and expanding its charter portfolio.", "Options positioning leans mildly bullish with a put-call ratio below 1."]
["Technical trend remains bearish with SMA_200 > SMA_20 > SMA_5.", "MACD is still below zero, indicating momentum remains weak.", "No AI Stock Picker signal and no recent SwingMax signal.", "Hedge funds and insiders are both neutral, with no notable buying activity.", "No congress trading data is available to suggest influential accumulation.", "The short-term pattern analysis suggests negative performance over the next week and month."]
No detailed financial snapshot was provided due to an error, so latest-quarter revenue and earnings growth cannot be verified from the dataset. The only financial-season-related update available is that the analyst upgrade followed the Q1 report, and the market reacted positively to the company’s improved long-term cash flow visibility and dividend increase. Based on the available information, the latest quarter appears to have been viewed favorably by analysts, but exact growth metrics are unavailable.
Recent analyst tone has improved. On 2026-04-30, Fearnley upgraded CMRE to Buy with a $21 target, and on 2026-05-05, Freedom Broker upgraded it to Buy from Hold and lifted the target to $21 from $19 after Q1. This is a clear positive shift in Wall Street sentiment. Pros: higher cash flow visibility, charter expansion, dividend growth, and rising price targets. Cons: the stock price and technical trend have not yet confirmed that optimism, so the street is more constructive than the chart.
